ClinicalTrials.govpublic full text
EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas
brain cancer, gliomas, erlotinib, glioblastoma, gbm, gliosarcoma, glioma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1008769
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.